These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28439927)

  • 1. Antithrombotic therapy and platelet transfusions in hematologic malignancy patients presenting chemotherapy-induced thrombocytopenia: a French survey.
    Chalayer E; Cavalieri D; Martignoles JA; Genthon A; Tavernier E; Tardy B
    Transfusion; 2017 Jul; 57(7):1717-1723. PubMed ID: 28439927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of anticoagulation in thrombocytopenic patients with hematologic malignancies: A case series.
    Campbell PM; Ippoliti C; Parmar S
    J Oncol Pharm Pract; 2017 Apr; 23(3):220-225. PubMed ID: 26854266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet transfusion and anticoagulation in hematological cancer-associated thrombosis and thrombocytopenia: The CAVEaT multicenter prospective cohort.
    Booth S; ; Desborough M; Curry N; Stanworth S
    J Thromb Haemost; 2022 Aug; 20(8):1830-1838. PubMed ID: 35505495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients treated for acute VTE during periods of treatment-related thrombocytopenia have high rates of recurrent thrombosis and transfusion-related adverse outcomes.
    Samuelson Bannow BT; Walter RB; Gernsheimer TB; Garcia DA
    J Thromb Thrombolysis; 2017 Nov; 44(4):442-447. PubMed ID: 28884390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematologic malignancies and thrombosis.
    Elice F; Rodeghiero F
    Thromb Res; 2012 Mar; 129(3):360-6. PubMed ID: 22197450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of menorrhagia associated with chemotherapy-induced thrombocytopenia in women with hematologic malignancy.
    Bates JS; Buie LW; Woodis CB
    Pharmacotherapy; 2011 Nov; 31(11):1092-110. PubMed ID: 22026397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Warkentin TE; Greinacher A
    Chest; 2004 Sep; 126(3 Suppl):311S-337S. PubMed ID: 15383477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of chemotherapy-induced thrombocytopenia in patients with gynecologic cancer.
    Goldberg GL; Gibbon DG; Smith HO; DeVictoria C; Runowicz CD; Burns ER
    J Clin Oncol; 1994 Nov; 12(11):2317-20. PubMed ID: 7964946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability in management of hematologic malignancy patients with venous thromboembolism and chemotherapy-induced thrombocytopenia.
    Samuelson BT; Gernsheimer T; Estey E; Garcia DA
    Thromb Res; 2016 May; 141():104-5. PubMed ID: 26994682
    [No Abstract]   [Full Text] [Related]  

  • 10. [The efficacy and safety of autologous cryopreserved platelet transfusion in management of thrombocytopenia after chemotherapy in hematological malignancy].
    Liu GQ; Ding HF; Lu XJ; Xu M; Xing J; Zhao X; Han F; Shang YH
    Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):188-91. PubMed ID: 22781890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet transfusion in hematology, oncology and surgery.
    Wandt H; Schäfer-Eckart K; Greinacher A
    Dtsch Arztebl Int; 2014 Nov; 111(48):809-15. PubMed ID: 25512006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
    Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G;
    Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose reductions and delays: limitations of myelosuppressive chemotherapy.
    Cairo MS
    Oncology (Williston Park); 2000 Sep; 14(9 Suppl 8):21-31. PubMed ID: 11033835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia.
    Zeidler K; Arn K; Senn O; Schanz U; Stussi G
    Transfusion; 2011 Nov; 51(11):2269-76. PubMed ID: 21517892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rational approach to the diagnosis and management of thrombocytopenia in the hospitalized patient.
    Arnold DM; Lim W
    Semin Hematol; 2011 Oct; 48(4):251-8. PubMed ID: 22000090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study.
    Niers TM; Di Nisio M; Klerk CP; Baarslag HJ; Büller HR; Biemond BJ
    J Thromb Haemost; 2007 Sep; 5(9):1878-82. PubMed ID: 17723127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home parenteral nutrition-associated thromboembolic and bleeding events: results of a cohort study of 236 individuals.
    Barco S; Heuschen CB; Salman B; Brekelmans MP; Serlie MJ; Middeldorp S; Coppens M
    J Thromb Haemost; 2016 Jul; 14(7):1364-73. PubMed ID: 27122107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
    Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT; Winton EF; Khoury HJ
    Cancer; 2013 Nov; 119(21):3784-7. PubMed ID: 23921838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative management of chemotherapeutic-induced thrombocytopenia in women with gynecologic cancers.
    Fanning J; Hilgers RD; Murray KP; Bolt K; Aughenbaugh DM
    Gynecol Oncol; 1995 Nov; 59(2):191-3. PubMed ID: 7590471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
    Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
    Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.